Anti-tumour necrosis factor-alpha agent therapy, compared with conventional therapy, reduces the relapse of uveitis in patients with behçet's disease: A systematic review of controlled trials

• Asıl Yazarlar: Xinwei Zhou (Yazar), Xianghui Shi (Yazar), Yanxia Ren (Yazar), Tingting Yan (Yazar), Qiao Ye (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2022-08-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Purpose: Anti-tumour necrosis factor-alpha (TNF-α) agents are often used for Behçet's disease (BD) in clinical practice, but they have not been validated by a high level of evidence. We systematically reviewed published controlled trials to investigate the efficacy and safety of anti-TNF-α ther...